Diffuse, purulent, necrotizing, bacterial inflammation (subcutaneous, subfascial, intramuscular) spreading into tissue clefts with broad tissue fusion.
S.a.
Images (2)
PhlegmonsL03.8
DefinitionThis section has been translated automatically.
EtiopathogenesisThis section has been translated automatically.
Frequently streptococcus (Streptodermia phlegmonosa) or staphylococcus infection (Staphylodermia phlegmonosa), also gram-negative germs and mixed flora. After minor injuries, e.g. panaritia, erysipelas, thrombophlebitis, rapid invasion of the bloodstream and lymphatic system.
Clinical featuresThis section has been translated automatically.
LaboratoryThis section has been translated automatically.
Leukocytosis, BSG elevation.
TherapyThis section has been translated automatically.
Immobilize and, if possible, elevate affected body parts.
External therapyThis section has been translated automatically.
Moist dressings with antiseptic additives such as potassium permanganate (light pink) or quinolinol (e.g. quinosol 1:1000 or R042 ).
Internal therapyThis section has been translated automatically.
Antibiosis after antibiogram, initial dicloxacillin (e.g. InfectoStaph) 2-4 g/day in 4-6 ED. Furthermore, due to the mixed infection of staphylococcus and streptococci, effective treatment with clindamycin or flucloxacillin is possible. In severe and resistant cases, hospital admission and targeted i.v. antibiotics, initially e.g. gentamicin (e.g. refobacin) once/day 240 mg p.o. and ceftriaxone (e.g. rocephin) once/day 2 g i.v. Ultima ratio: surgical debridement
Operative therapieThis section has been translated automatically.
In case of fluctuation, wide incision, irrigation with antiseptic solutions such as polyvidon-iodine solution (e.g. Betaisodona), drainage/ladder insert and then antiseptic dressings with polyvidon-iodine ointment (e.g. Braunovidon).